IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis

PLoS ONE

Volumn 3, Issue 12, 2008, Pages

  Meyer, Rosana D ^a   Sacks, David B ^b   Rahimi, Nader ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CBL PROTEIN; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; PROTEIN SH2; VASCULOTROPIN RECEPTOR 2; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PROTEIN TYROSINE KINASE; TYROSINE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CHORIOALLANTOIS; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; NEOPLASM; NONHUMAN; POSITIVE FEEDBACK; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RETINA MACULA AGE RELATED DEGENERATION; SIGNAL TRANSDUCTION; ANIMAL; CHICKEN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHOSPHORYLATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CHICKENS; ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-CBL; RAS GTPASE-ACTIVATING PROTEINS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 57349159403     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003848     Document Type: Article

References (33)

1. Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438: 932-936.
2. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol 7: 359-371.
3. Dayanir V, Meyer RD, Lashkari K, Rahimi N (2001) Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. J Biol Chem 276: 17686-17692.
4. Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, et al. (2005) A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437: 426-431.
5. Takahashi T, Yamaguchi S, Chida K, Shibuya M (2001) A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J 20: 2768-2778.
6. Meyer RD, Latz C, Rahimi N (2003) Recruitment and activation of phospholipase Cgamma1 by vascular endothelial growth factor receptor-2 are required for tubulogenesis and differentiation of endothelial cells. J Biol Chem 278: 16347-16355.
7. Holmqvist K, Cross MJ, Rolny C, Hagerkvist R, Rahimi N, et al. (2004) The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. J Biol Chem 279: 22267-22275.
8. Igarashi K, Shigeta K, Isohara T, Yamano T, Uno I (1998) Sck interacts with KDR and Flt-1 via its SH2 domain. Biochem Biophys Res Commun 251: 77-82.
9. Warner AJ, Lopez-Dee J, Knight EL, Feramisco JR, Prigent SA (2000) The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells. Biochem J 347: 501-509.
10. Ratcliffe KE, Tao Q, Yavuz B, Stoletov KV, Spring SC, et al. (2002) Sck is expressed in endothelial cells and participates in vascular endothelial growth factor-induced signaling. Oncogene 21: 6307-6316.
11. Sakurai Y, Ohgimoto K, Kataoka Y, Yoshida N, Shibuya M (2005) Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc Natl Acad Sci U S A 102: 1076-1081.
12. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, et al. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66.
13. Zeng H, Sanyal S, Mukhopadhyay D (2001) Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively. J Biol Chem 276: 32714-32719.
14. Singh AJ, Meyer RD, Navruzbekov G, Shelke R, Duan L, et al. (2007) A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis. Proc Natl Acad Sci U S A 104: 5413-5418.
15. Meyer RD, Dayanir V, Majnoun F, Rahimi N (2002) The presence of a single tyrosine residue at the carboxyl domain of vascular endothelial growth factor receptor-2/FLK-1 regulates its autophosphorylation and activation of signaling molecules. J Biol Chem 277: 27081-27087.
16. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, et al. (1999) Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4: 915-924.
17. Alavi A, Hood JD, Frausto R, Stupack DG, Cheresh DA (2003) Role of Raf in vascular protection from distinct apoptotic stimuli. Science 301: 94-96.
18. Rahimi N (2006) VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy. Front Biosci 11: 818-829.
19. Marengere LE, Songyang Z, Gish GD, Schaller MD, Parsons JT, et al. (1994) SH2 domain specificity and activity modified by a single residue. Nature 369: 502-505.
20. Rahimi N, Dayanir V, Lashkari K (2000) Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells. J Biol Chem 275: 16986-16992.
21. Singh AJ, Meyer RD, Band H, Rahimi N (2005) The carboxyl terminus of VEGFR-2 is required for PKC-mediated down-regulation. Mol Biol Cell 16: 2106-2118.
22. Sanjay A, Miyazaki T, Itzstein C, Purev E, Horne WC, et al. (2006) Identification and functional characterization of an Src homology domain 3 domain-binding site on Cbl. FEBS J 273: 5442-5456.
23. Nolen B, Taylor S, Ghosh G (2004) Regulation of protein kinases; controlling activity through activation segment conformation. Mol Cell 15: 661-675.
24. Klinghoffer RA, Sachsenmaier C, Cooper JA, Soriano P (1999) Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J 18: 2459-2471.
25. Summy JM, Gallick GE (2003) Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22: 337-358.
26. Yamaoka-Tojo M, Ushio-Fukai M, Hilenski L, Dikalov SI, Chen YE, et al. (2004) IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species-dependent endothelial migration and proliferation. Circ Res 95: 276-283.
27. Ren JG, Li Z, Sacks DB (2007) IQGAP1 modulates activation of B-Raf. Proc Natl Acad Sci U S A. 104: 10465-10469.
28. Tanaka S, Amling M, Neff L, Peyman A, Uhlmann E, et al. (1996) c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Nature 383: 528-531.
29. Bao J, Gur G, Yarden Y (2003) Src promotes destruction of c-Cbl: implications for oncogenic synergy between Src and growth factor receptors. Proc Natl Acad Sci U S A 100: 2438-2443.
30. Meyer RD, Singh A, Majnoun F, Latz C, Lashkari K, et al. (2004) Substitution of C-terminus of VEGFR-2 with VEGFR-1 promotes VEGFR-1 activation and endothelial cell proliferation. Oncogene 23: 5523-5531.
31. Roy M, Li Z, Sacks DB (2004) IQGAP1 binds ERK2 and modulates its activity. J Biol Chem 279: 17329-17337.
32. Takahashi T, Ueno H, Shibuya M (1999) VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 18: 2221-2230.
33. Briggs MW, Sacks DB (2003) IQGAP proteins are integral components of cytoskeletal regulation. EMBO Rep 4: 571-574.